Zoledronic acid, also known as zoledronate and sold under the brand name Zometa by Novartis among others, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, Paget's disease of bone and Duchenne muscular dystrophy (DMD). It is given by injection into a vein. WebbZometa contains the same active ingredient as found in Reclast ® (zoledronic acid). Patients being treated with Zometa should not be treated with Reclast or other bisphosphonates. hydration & electrolyte monitoring. Patients with hypercalcemia of malignancy must be adequately rehydrated prior to administration of Zometa.
Reclast (zoledronic acid) - MedicineNet
WebbReclast should be used with caution in patients who are taking drugs that affect kidney function because Reclast has been associated with reduced kidney function. Since Reclast contains the same active ingredient as zoledronic acid ( Zometa ), patients treated with Zometa should not receive Reclast. Webb• Patients being treated with Zometa should not be treated with Reclast ®. (5.1) • Adequately rehydrate patients with hypercalcemia of malignancy prior to administration of Zometa and monitor electrolytes during treatment. (5.2) • Renal toxicity may be greater in patients with renal impairment. Do not use great birthday wishes for cousin
Zometa infusion & breast cancer Mayo Clinic Connect
Webb14 jan. 2024 · A new study suggests frequent Zometa injections ... to carry a similar risk of jawbone cellular death which has been linked to other bone-strengthening drugs from the same ... Reclast, is a daily ... Webb11 jan. 2024 · Similarly, the manufacturer of Reclast recommends stopping Reclast if you become pregnant. If you have acute kidney failure or severe kidney damage, avoid taking Reclast. Also, don’t take Reclast if you’re taking the medication Zometa because they contain the same ingredient — zoledronic acid. great bison belt definition